This inventor holds 1 USPTO granted patent. Top assignee: University of Oklahoma. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations by Peter Moore in Urinary Tract Tissue Engineering
Introduction
Peter Moore is an accomplished inventor based in Perry, Oklahoma. He has made significant contributions to the field of tissue engineering, particularly in developing methods for creating urinary tract tissue grafts. His innovative work has the potential to improve medical treatments for patients requiring urinary tract repairs.
Latest Patents
Peter Moore holds a patent for "Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same." This patent describes a method for providing a urinary tract tissue graft composition. The process involves using a tissue culture frame and a segment of small intestinal submucosa, which is positioned in a way that allows it to be suspended and held taut. The method includes isolating and culturing smooth muscle and urothelial cells from a tissue specimen, which are then seeded onto the submucosa segment to form a urinary tract tissue graft.
Career Highlights
Peter Moore is affiliated with the University of Oklahoma, where he continues to advance his research in tissue engineering. His work has garnered attention for its innovative approach to addressing complex medical challenges. With a focus on regenerative medicine, he aims to enhance the quality of life for patients with urinary tract issues.
Collaborations
Some of Peter Moore's notable coworkers include Bradley P. Kropp and Earl Y. Cheng. Their collaborative efforts contribute to the ongoing research and development in the field of tissue engineering.
Conclusion
Peter Moore's contributions to urinary tract tissue engineering exemplify the impact of innovation in medical science. His patented methods and ongoing research hold promise for future advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
